Dennis C. Ang, MD, MS

About Me

Education: Master's Degree, Case Western Reserve, 2001
Internship: Internal Medicine, Cleveland Clinic Foundation, 1995
Residency: Internal Medicine, Cleveland Clinic Foundation, 1995
Fellowship: Internal Medicine, Cleveland Clinic, 1999
Board Certifications: American Board of Internal Medicine, Internal Medicine; American Board of Internal Medicine, Rheumatology
Memberships: American College of Rheumatology; American Pain Society
Positions: Professor, Rheumatology and Immunology
Departments and Affiliations: Rheumatology and Immunology

Obesity Moderates the Effects of Motivational Interviewing Treatment Outcomes in Fibromyalgia.. Kaleth AS, Slaven JE, Ang DC. Clin J Pain. 2018 Jan; 34(1):76-81.
Biologic Therapies for Autoimmune and Connective Tissue Diseases.. Wolfe RM, Ang DC. Immunol Allergy Clin North Am. 2017 05; 37(2):283-299.
Determining the Minimal Clinically Important Difference for 6-Minute Walk Distance in Fibromyalgia.. Kaleth AS, Slaven JE, Ang DC. Am J Phys Med Rehabil. 2016 Oct; 95(10):738-45.
Mast Cell Stabilizer (Ketotifen) in Fibromyalgia: Phase 1 Randomized Controlled Clinical Trial.. Ang DC, Hilligoss J, Stump T. Clin J Pain. 2015 Sep; 31(9):836-842.
Metformin: Potential analgesic?. Smith B, Ang D. Pain Med. 2015 Dec; 16(12):2256-60.

View More Publications